Table 2 XTT Reduction assay results
From: Clinical implications of microbial biofilms in chronic rhinosinusitis and orbital cellulitis
Drug concentration in μg per ml | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Lab. No | 32 | 16 | 8 | 4 | 2 | 1 μ | 0.5 | 0.25 | Positive control | Negative control |
39/12/9 | 2.307 | 3.011 | 2.894 | 2.793 | 3.372 | 3.325 | 3.325 | 3.306 | 3.316 | 0.143 |
20/13/9 | 1.876 | 2.002 | 1.997 | 2.297 | 2.833 | 2.176 | 2.961 | 3.506 | 3.522 | 0.167 |
29/3/9 | 1.604 | 1.632 | 1.656 | 1.788 | 1.823 | 2.772 | 2.827 | 2.884 | 3.513 | 0.18 |
30/3/11 | 1.337 | 2.421 | 2.557 | 2.697 | 2.697 | 2.971 | 2.986 | 2.999 | 2.985 | 0.199 |
16/5/6 | 0.941 | 1.14 | 1.477 | 1.419 | 1.563 | 1.596 | 2.247 | 2.564 | OVRFLW | 0.047 |
19/15/12 | 1.499 | 1.499 | 1.512 | 1.516 | 2.555 | 2.794 | 2.819 | 3.436 | 3.538 | 0.098 |
21/15/12 | 0.941 | 1.14 | 1.477 | 1.419 | 1.563 | 1.596 | 2.247 | 2.564 | OVEFLW | 0.1 |
12/23/2011 | 1.559 | 1.776 | 2.667 | 3.14 | 3.241 | 3.256 | 3.312 | 3.323 | 3.113 | 0.145 |